Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Lyndra names Adam Sayer president and CEO

Plus: Martin Olin becomes CEO of Swarm, and updates from Totus, Nmdp and Vortex

By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst
January 29, 2025 1:41 AM UTC

Lyndra Therapeutics Inc., which is developing long-acting oral therapies, named Adam Sayer president, CEO and board member. Sayer succeeds Jessica Ballinger and was chief transformation officer at Envision Healthcare.

Swarm Oncology Ltd. named Martin Olin CEO. Olin was CEO of Bergenbio ASA and Symphogen A/S. The U.K. biotech was co-founded by CSO John Campbell and Delin Ventures to develop T cell therapies for solid tumors. ...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Lyndra Therapeutics Inc.

Totus Medicines Inc.

Vortex Biosciences Inc.